Across TCGA pan-cancer cohorts, GAS2L1P2 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of GAS2L1P2’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where GAS2L1P2 RNA is repressed in tumor relative to normal tissue. In most cancer types GAS2L1P2 is over-expressed in tumor, although a few such as KIRP and KIRC show the opposite, repressed pattern.
KIRP, KIRC, and THCA are the cancer types where GAS2L1P2 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GAS2L1P2 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.